Ginkgo biloba: local experiences.
Ginkgo biloba (EGb 761) as a phytotherapeutic agent used in otoneurology, psychiatry, and ophthalmology. We studied the efficacy of therapy with EGb 761 in 72 patients (44 male and 28 female) with chronic cochleovestibular disorders. We used pure-tone audiology, measuring pure-tone average, speech reception threshold, and speech discrimination score. Then we used craniocorpography to measure lateral body sway and angular deviation. Finally, we used nystagmography (central nystagmic frequency). Also, we assessed subjectively the variation in patients' comfort. We concluded that EGb 761 has a very good effect on both postural and oculovestibular reflexes. Also, hearing was improved, and patients' comfort was considered to be heightened by the therapy.
Hahn
A
A
Ear, Nose, and Throat Department, Third Medical Faculty, Charles University, Srobárova 50, Prague, 100 34, Czech Republic.
Stolbova
K
K
D001299:Audiometry; D001309:Auditory Threshold / Q000187:drug effects*; D004584:Electronystagmography; D005260:Female; D020441:Ginkgo biloba; D006801:Humans; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D016896:Treatment Outcome; D015837:Vestibular Diseases / Q000188:drug therapy* / Q000503:physiopathology; D000096983:Ginkgo Extract
D010936:Plant Extracts; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract